Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza

Clinical Infectious Diseases

Volumn 68, Issue 6, 2019, Pages 895-902

  Uyeki, Timothy M ^a   Bernstein, Henry H ^b   Bradley, John S ^c,d   Englund, Janet A ^e   File, Thomas M ^f   Fry, Alicia M ^a   Gravenstein, Stefan ^g   Hayden, Frederick G ^h   Harper, Scott A ⁱ   Hirshon, Jon Mark ^j   Ison, Michael G ^k   Johnston, B Lynn ^l   Knight, Shandra L ^m   McGeer, Allison ⁿ   Riley, Laura E ^o   Wolfe, Cameron R ^p   Alexander, Paul E ^q,r   Pavia, Andrew T ^s  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Northwell Health   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^j UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l DALHOUSIE UNIVERSITY   (Canada)

^m DEPARTMENT OF MEDICINE   (United States)

ⁿ Women s College Hospital   (Canada)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p DUKE UNIVERSITY MEDICAL CENTER   (United States)

^q MCMASTER UNIVERSITY   (Canada)

^r Infectious Diseases Society of America Emerging Infections Network   (United States)

^s UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

chemoprophylaxis; diagnostic testing; influenza; institutional outbreaks; seasonal; treatment

Indexed keywords

ANTIVIRUS AGENT; IMMUNOMODULATING AGENT; INFLUENZA VACCINE;

ANTIVIRAL THERAPY; BACTERIAL INFECTION; CHEMOPROPHYLAXIS; HOSPITAL PATIENT; HUMAN; LONG TERM CARE; LOWER RESPIRATORY TRACT INFECTION; MIXED INFECTION; NONHUMAN; POST EXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; REVIEW; SEASONAL INFLUENZA; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; DISEASE MANAGEMENT; EPIDEMIC; INFLUENZA; SEASON; ANTIVIRAL RESISTANCE; CLINICAL TRIAL; CRITICAL ILLNESS; GERIATRIC PATIENT; HEALTH CARE PERSONNEL; IMMUNOCOMPROMISED PATIENT; IMMUNOTHERAPY; INFECTION CONTROL; LUNG DISEASE; MEDICAL SPECIALIST; PEDIATRIC PATIENT; PREGNANCY; PRESCRIPTION;

CHEMOPREVENTION; DISEASE MANAGEMENT; DISEASE OUTBREAKS; HUMANS; INFLUENZA, HUMAN; SEASONS;

EID: 85062100120     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciy874     Document Type: Review

References (17)

1. Tokars JI, Olsen SJ, Reed C. Seasonal incidence of symptomatic influenza in the United States. Clin Infect Dis 2018; 66:1511–18.
2. Poehling KA, Edwards KM, Weinberg GA, et al; New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:31–40.
3. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303:1517–25.
4. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis 2012; 54:1427–36.
5. Thompson WW, Moore MR, Weintraub E, et al. Estimating influenza-associated deaths in the United States. Am J Public Health 2009; 99(Suppl 2):S225–30.
6. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086–96.
7. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333–40.
8. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza—United States, 1976–2007. MMWR Morb Mortal Wkly Rep 2010; 59:1057–62.
9. Centers for Disease Control and Prevention. Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. Available at: https://www.cdc.gov/flu/about/disease/2015–16.htm.
10. Iuliano AD, Roguski KM, Chang HH, et al; Global Seasonal Influenza-Associated Mortality Collaborator Network. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391:1285–300.
11. Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003; 112:363–7.
12. Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 2007; 167:354–60.
13. Hsu J, Santesso N, Mustafa R, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med 2012; 156:512–24.
14. Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014; CD008965.
15. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009–2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013; 207:553–63.
16. Muthuri SG, Venkatesan S, Myles PR, et al; PRIDE Consortium Investigators. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014; 2:395–404.
17. Harper SA, Bradley JS, Englund JA, et al; Expert Panel of the Infectious Diseases Society of America. Seasonal influenza in adults and children–diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003–32.